COVD-09. INVESTIGATION AND SUMMARY OF DIAGNOSIS AND TREATMENT OF NEUROLOGICAL TUMORS DURING COVID-19 IN CHINA

In order to realize the condition of diagnosis and treatment of neurological tumors in China during COVID-19, CSNO (China Anti-Cancer Association Neuro-Oncology Professional Committee) organized this questionnaire survey. The survey was conducted online from June 3rd to 16th in 2020. A total of 373 replies were received and 370 were confirmed valid questionnaires. The respondents were mainly neurosurgeons, as well as radiotherapists and pathologists in general hospitals and specialized hospitals in 29 provinces and municipalities in China. The survey results are summarized as follows. Firstly, the number of outpatient and inpatient of neurological tumors significantly declined during the epidemic compared with the same period last year in more than 90% of hospitals surveyed, and a few specialized hospitals even stopped treatment due to the outbreak of COVID-19. Compelled by illness was the main reason for most of the patients to go to hospital. As the epidemic prevention and controlling, the normal treatment process for each patient was tedious than that for the same period before, and the costing time also turned longer. Most patients might feel poor medical experience, but they also expressed understanding for the hospital and cooperated with the diagnosis and treatment works. Secondly, during the epidemic period, the participation in academic conferences or MDT decreased significantly for most doctors, and scientific research work even stopped in some hospitals. Online tools have risen as the primary means of communication, not only for academic communication but also for diagnosis and treatment works. More than 90% of doctors believe the style of online communication was a new mode in this special period, with advantages such as convenient and quick. It could be an effective supplement to daily work and would be utilized into work in future.